FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
Biotronik has received U.S. Food and Drug Administration (FDA) approval for its Solia CSP S pacing lead, growing access to a solution for Left Bundle Branch Area Pacing (LBBAP).
The post FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP appeared first on MedTech Intelligence.